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The utility of human pluripotent stem cells is dependent on efficient differentiation protocols that
convert these cells into relevant adult cell types. Here we report the robust and efficient
differentiation of human pluripotent stem cells into white or brown adipocytes. We found that
inducible expression of PPARG2 alone or combined with CEBPB and/or PRDM16 in
mesenchymal progenitor cells derived from pluripotent stem cells programmed their development
towards a white or brown adipocyte cell fate with efficiencies of 85%–90%. These adipocytes
retained their identity independent of transgene expression, could be maintained in culture for
several weeks, expressed mature markers and had mature functional properties such as lipid
catabolism and insulin-responsiveness. When transplanted into mice, the programmed cells gave
rise to ectopic fat pads with the morphological and functional characteristics of white or brown
adipose tissue. These results indicate that the cells could be used to faithfully model human
disease.
The derivation of human embryonic stem cells1 (hESCs) and generation of human induced
pluripotent stem cells2,3 (hiPSCs) have made possible the creation of patient-specific in vitro
cell models. As human pluripotent stem cells (hPSCs) self-renew and have the potential to
differentiate into any adult cell type, they represent an inexhaustible supply of cells for
studying normal cell function and disease pathogenesis. Although the number of patient-
derived hiPSC lines is rapidly increasing4,5, the principal obstacle for understanding disease
remains the difficulty of differentiating hPSCs into adult cell types.
White adipose tissue, which is specialized for energy storage, is readily obtained from
patients but is difficult to maintain and cannot expand in culture. Much of our insight into
the differentiation and transcriptional regulation of adipocytes has come from the mouse cell
line 3T3-L1, which can be differentiated into white adipocytes by exposure to a combination
of factors6,7 and was used to identify the transcription factor peroxisome proliferator-
activated receptor γ2 (PPARG2; ref. 8), widely regarded as a master regulator of
adipogenesis9.
Brown adipose tissue uses the chemical energy in lipids and glucose to produce heat through
non-shivering thermogenesis10. The recent discovery that adult humans have brown adipose
depots of a size that is inversely correlated with body mass index11–13 has fuelled
considerable interest in the therapeutic potential of brown adipocytes. The transcription
factors encoded by CCAAT/enhancer-binding protein beta (CEBPB) and PR domain
containing 16 (PRDM16) are thought to function as key regulators of brown fat
development and function14,15.
A number of groups have developed human-cell-based models for the study of adipogenesis
using either mesenchymal stem cells (MSCs) from bone marrow or other tissues16,17 or
adipose-derived stromal vascular cells18 (ADSVCs). Although these cellular systems have
proved useful, they have limitations including limited proliferative potential, decreased
differentiation with continued passaging19 and variable differentiation potential. To
overcome these obstacles, several groups have sought to use hPSCs to generate human
adipocytes, but reports so far have been limited to white adipocytes20–23. Moreover, the
efficient generation of large numbers of hPSC-derived adipocytes, with detailed phenotypic
characterization that documents fidelity to primary cells, has remained elusive. For hPSCs to
be useful cellular models of adipose-related disease, it is necessary to develop reliable and
scalable protocols for their differentiation into adipocytes. Here we report simple, consistent
and highly efficient protocols to generate mature functional adipocytes—either white or
brown—from hPSCs.
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RESULTS
Differentiation of hPSCs to MPCs
Several protocols for generating MSCs or mesenchymal progenitor cells (MPCs) from
hPSCs have previously been described24,25. Notably, these cells had the potential to form
adipocytes. We sought to simplify the derivation of MPCs from hPSCs (Fig. 1a and
Supplementary Fig. S1A). Three hESC lines and two hiPSC lines26 were differentiated into
embryoid bodies that after two days in suspension culture had a characteristic rounded shape
with defined and smooth borders. After ten days, these embryoid bodies were plated to
adherent cell culture dishes, and fibroblast-like cells were observed growing from the
embryoid bodies (Supplementary Fig. S1B). We analysed the expression levels of
pluripotency genes and mesoderm development genes at different stages during the
differentiation protocol (Supplementary Fig. S1C). We observed a transient increase in
expression of the mesendoderm marker goosecoid (GSC) during differentiation and the level
of expression declined after prolonged culture of the fibroblast-like cells. The mesodermal
marker T-box transcription factor 3 (TBX3) was absent in the pluripotent stage but was
expressed during differentiation, and expression was maintained in cultured fibroblast-like
cells. NANOG, a marker of pluripotency, was observed at very high levels in pluripotent
cells but rapidly diminished during differentiation.
The derived fibroblast-like cells were replicative and were capable of expansion for 10–12
passages. We analysed these cells with flow cytometry for markers characteristic of an MSC
fate—Stro1, CD29, CD105, CD73 and CD44—and negative control markers of the blood
lineage—CD19 and CD4 (Fig. 1b and Supplementary Fig. S2A–D). We found that more
than 96% of the fibroblast-like cells expressed CD73, CD29, CD44 and CD105; ADSVCs
similarly expressed CD73, whereas hPSCs lacked the CD73 surface antigen entirely. Global
transcriptional analysis of the derived cells showed high similarity to a variety of MSC lines
(Supplementary Fig. S3). We were able to differentiate the fibroblast-like cells into
osteoblasts and chondrocytes (Supplementary Fig. S1D,E) and adipocytes (see below). In
light of the characteristic markers and the trilineage differentiation results, we hereafter term
the fibroblast-like cells MPCs.
Differentiation of MPCs into white adipocytes
To determine whether our hPSC-derived MPCs could generate white adipocytes as
previously reported24,27, we examined their response to known inducers of adipogenesis—
insulin, rosiglitazone and dexamethasone; for comparison we used human ADSVCs. After
21 days of exposure to a combination of these factors, a small percentage of MPCs and
ADSVCs contained multilocular lipid droplets resembling those often found in immature
white adipocytes (Fig. 2b, top panels and Supplementary Fig. S4A–D). ADSVC lines from
distinct donors showed considerable variation in their ability to differentiate into white
adipocytes, 10%–70%, as has previously been reported28. The white adipocyte
differentiation potential of MPC lines was also variable and was less than that of ADSVCs;
only 3%–10% of MPCs differentiated into white adipocytes (Fig. 2a).
Programming MPCs into white adipocytes
We attempted to improve the differentiation of MPCs to white adipocytes with the
temporally controlled expression of a programming factor, namely PPARG2, a key regulator
of adipogenesis9,29–31. MPCs were transduced with a lentiviral construct with a
doxycycline-inducible promoter driving PPARG2 complementary DNA expression (lenti-
tet–PPARG2) and a construct constitutively expressing the reverse tetracycline
transactivator32 (lenti-rtTA) allowing controlled expression of PPARG2 (Fig. 1c). We
determined that the transduction efficiency of MPCs was approximately 98% (s.d. ±1%) as
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measured by the proportion of GFP-positive cells following infection with lentiviral
concentrations of greater than 375 copies per cell (Supplementary Fig. S5A,B). MPCs or
ADSVCs were cultured in adipogenic media (differentiated) and either transduced
(programmed) or not (unprogrammed) with lenti-tet-PPARG2 and lenti-rtTA (ref. 32) in the
presence of doxycycline for 16 days, after which the doxycycline was removed from the
media and the cells were cultured for an additional five days (Fig. 1a) to generate transgene-
independent adipocytes. After 21 days, we consistently observed that most PPARG2-
programmed, differentiated MPCs had the typical morphology of mature white adipocytes,
with a single large, well-defined lipid droplet, in contrast to unprogrammed, differentiated
MPCs (Fig. 2a–c).
To determine the efficiency of white adipocyte differentiation, hPSC-derived adipocytes
were immunostained with an antibody against CCAAT/enhancer-binding protein alpha
(CEBPA; Fig. 2a). By counting the number of CEBPA-positive nuclei, we determined that
on average 88% of PPARG2-programmed, differentiated MPCs were white adipocytes,
compared with 9% of unprogrammed, differentiated MPCs (n = 3). We immunostained
programmed and unprogrammed MPCs at day 21 of differentiation with antibodies against
fatty-acid-binding protein 4 (FABP4), PPARG2 and CEBPA (Fig. 2b,c). We observed
strong staining of the cytoplasm with antibodies against FABP4 and nuclear staining with
antibodies against PPARG2 and CEBPA. The cells were also stained with BODIPY and had
a morphology characteristic of mature white adipocytes, with most positively stained cells
containing one large, predominant lipid droplet and a few surrounding small droplets. To
confirm that the hPSC-derived white adipocytes were not dependent on transgene
expression, we cultured the cells for up to four additional weeks in the absence of
doxycycline. Twenty days after doxycycline withdrawal, these cells maintained the
morphologic appearance of mature adipocytes, incorporated BODIPY, stained positive for
CEBPA and exhibited minimal expression of lentivirus-specific PPARG2 (Supplementary
Fig. S4E). Furthermore, we investigated the kinetics of PPARG2-programmed
differentiation into adipocytes. To that end we differentiated the cells for 21 days and
withdrew doxycycline at different time points and examined the gene expression of
adipogenic markers by quantitative polymerase chain reaction with reverse transcription
(RT–qPCR; Supplementary Fig. S8B). For the markers encoded by hormone-sensitive lipase
(HSL) and adiponectin (ADIPOQ), a plateau was reached after 14 days of doxycycline
administration. FABP4 showed the highest level of expression after 16 days of doxycycline
administration. Thus, our data indicate that a 16-day pulse of PPARG2 expression is
sufficient to permanently switch the fate of MPCs to the white adipocyte lineage.
Programming MPCs into brown adipocytes
We extended our programming approach to achieve differentiation of MPCs into brown
adipocytes. PRDM16 has previously been shown to convert murine myoblasts into brown
adipocytes33, and a combination of CEBPB and PRDM16 to convert mouse cells and human
fibroblasts into adipocytes with brown adipocyte characteristics15. Accordingly, to generate
brown adipocytes, we transduced MPCs with combinations of doxycycline-inducible
lentiviral constructs (Supplementary Fig. S5D) encoding the transcription factors PPARG2,
CEBPB and PRDM16 and differentiated the cells in doxycyline-containing adipogenic
medium. Generally, doxycycline was removed from the media after 14 days in culture and
the cells were cultured for an additional 7 days (Fig. 1a). Three transcription factor
combinations showed a statistically significant increase in the level of expression of
uncoupling protein 1 (UCP1; n = 3; Supplementary Fig. S5E). This included the previously
reported transcription factor combination CEBPB–PRDM16 as well as PPARG2–CEBPB
and PPARG2–CEBPB–PRDM16. We noted that combinations that included PPARG2
showed a much greater induction of UCP1. We also found that the expression of ADIPOQ
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and cell-death-inducing DFFA-like effector c (CIDEC) was similar among the three
transcription factor combinations and, notably, lower than that seen in white adipocytes
programmed with PPARG2 alone (Supplementary Fig. S5E). On the basis of these
observations, we chose to focus further work on two of the transcription factor
combinations, PPARG2–CEBPB and PPARG2–CEBPB–PRDM16.
After 21 days, we observed striking morphological differences between PPARG2-
programmed (white) adipocytes and PPARG2–CEBPB-programmed or PPARG2–CEBPB–
PRDM16-programmed (brown) adipocytes; programmed brown adipocytes generally had a
multilocular lipid droplet morphology, and very few cells had the monolocular appearance
noted in programmed white adipocytes (Fig. 2b–d). We stained programmed brown
adipocytes for UCP1 and noted strong staining of the cytoplasm, with almost no staining in
unprogrammed cells. We further stained programmed brown adipocytes with the
mitochondrial marker MitoTracker; we observed strong staining in the cytoplasm, with a
more diffuse morphology and much less staining in unprogrammed cells (Fig. 2d). These
findings were consistent with a brown adipocyte cell fate and distinguished the programmed
brown adipocytes from white adipocytes.
hPSC-derived adipocytes express mature markers
We carried out RT–qPCR for a panel of adipocyte marker genes, including lipoprotein
lipase (LPL), HSL, ADIPOQ, FABP4, CEBPA and PPARG2 (Supplementary Table S1), in
undifferentiated MPCs and ADSVCs and in unprogrammed or PPARG2-programmed,
differentiated cells (n = 3; Fig. 3a and Supplementary Fig. S8A). Adipocyte marker gene
expression was absent in the undifferentiated cell lines with the exception of PPARG2,
which was detected in ADSVCs as previously reported34,35. We found low levels of
expression of these genes in unprogrammed, differentiated MPCs and ADSVCs. In contrast,
PPARG2-programmed, differentiated MPCs and ADSVCs at day 21 exhibited high levels of
expression of all of the adipocyte marker genes, consistent with a mature white adipocyte
fate.
We next compared the expression signature of PPARG2-programmed white adipocytes with
PPARG2–CEBPB-programmed and PPARG2–CEBPB–PRDM16-programmed brown
adipocytes (n = 3; Fig. 3b). The level of gene expression was similar for the endogenous
PPARG2 gene and LPL. As expected, programmed white adipocytes showed a higher level
of expression of the white adipocyte markers ADIPOQ, HSL and FABP4 when compared
with programmed brown adipocytes; programmed brown adipocytes showed a higher level
of expression of the brown adipocyte markers UCP1 and elongation of very long chain fatty
acids like-3 (ELOVL3), and peroxisome proliferator-activated receptor γ1-α (PGC1A), a
major regulator of mitochondrial biogenesis, as well as the mitochondrial marker
cytochrome c1 (CYC1; ref. 36). Notably, these results were independent of transgene
expression (Supplementary Fig. S5C), confirming that the adipocyte markers observed were
the result of an endogenous cellular program.
Programmed white adipocytes have a transcriptional signature similar to primary
adipocytes
To evaluate how closely our hPSC-derived white adipocytes resembled primary white
adipocytes on a genome-wide scale, we generated and analysed transcript profiles from
undifferentiated and PPARG2-programmed, differentiated ADSVCs and MPCs in addition
to primary fat on two independent array platforms (Fig. 4a,b and Supplementary Fig. S6A–
D). Both platforms yielded highly concordant results using a significance analysis of
microarrays (SAM) algorithm to rank genes present on both platforms (Spearman rank
correlation = 0.84). Furthermore, overlap of differentially expressed genes at a 5% false
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discovery rate (FDR) between both platforms was extremely high (P < 10–300,
hypergeometric test). For the following analyses and figures, we will focus on the
Affymetrix data. Unsupervised clustering by the Pearson correlation coefficient for all of the
expressed genes (~20,000) resulted in two primary clusters: PPARG2-programmed white
adipocytes, derived from both MPCs and ADSVCs, and primary white fat (r = 0.95); and
undifferentiated ADSVCs and MPCs (r = 0.88). To determine the most significant changes
in gene expression between the programmed/primary adipocytes and undifferentiated
populations (ADSVCs and MPCs) we used the SAM algorithm to call 2,136 differentially
expressed genes using a 5% local FDR (Fig. 4a; ref. 37). We carried out Gene Ontology
(GO) term analysis using the DAVID Bioinformatics Resource38,39 and found that the most
prominently enriched gene sets in the 2,136 differentially expressed genes included
annotations for PPARG2 signalling pathways as well as metabolism and genesis of fatty
acids, and lipids (P < 10−6,10−9 and 10−10, respectively; Supplementary Table S2). We
further analysed the genes that showed the greatest differences between PPARG2-
programmed adipocytes and primary fat using the SAM algorithm and GO terms and
observed that many of these genes could be attributed to the various non-adipocyte cell
types present in adipose tissue, including red blood cells, leukocytes, vascular endothelium
and mesenchymal cells (Supplementary Table S3). Last, we examined a panel of adipocyte-
specific genes and found that the level of expression was higher in the programmed/primary
white adipocytes in comparison with the undifferentiated cells (Fig. 4b). Overall, the striking
similarity of the primary white fat samples with the programmed white adipocytes (r = 0.95)
indicates that PPARG2 induction is a reliable and reproducible methodology for the
derivation of homogeneous adipocytes from different hPSC types.
Programmed brown adipocytes have a distinct signature from white adipocytes
To assess our programmed brown adipocytes at the transcrip-tome level, we generated and
analysed transcript profiles from PPARG2–CEBPB-programmed and PPARG2–CEBPB–
PRDM16-programmed adipocytes and compared these with transcript profiles from primary
white adipose tissue in addition to undifferentiated and PPARG2-programmed,
differentiated ADSVCs and MPCs (Supplementary Fig. S6E). Hierarchical clustering with
Pearson’s correlation of 2,869 differentially expressed genes revealed that all of the adipose
samples (programmed brown, programmed white and primary white) co-segregate
separately from the undifferentiated samples (ADSVCs and MPCs; r = 0.86). Importantly,
within the adipose cluster, the programmed brown adipocytes (r = 0.95) cluster distinctly
from the programmed and primary white adipose (r = 0.90).
We then focused on a panel of genes that are associated with brown fat or white fat
identity36,40,41 (Fig. 4c). All of the genes that have been described as brown adipose tissue
markers (UCP1, CYC1, NDUFA11, NDUFA13, CMT1A, ELOVL3, DIO2, LHX8, COX8A
and CYFIP2) show the highest level of expression in programmed brown adipocytes, with
the only outlier being endogenous PRDM16, which showed the highest level of expression
in primary and programmed white adipocytes. All differentiated cells expressed general
adipocyte markers (CIDEC, PLIN1 and FABP4) at much higher levels than undifferentiated
cells. Genes associated with white fat identity (DPT and INHBB) were most highly
expressed in programmed and primary white adipocytes.
To confirm the low level of expression of PRDM16 in programmed brown adipocytes, we
carried out RT–qPCR using a primer that detects only endogenous PRDM16 as well as a
primer that detects viral and endogenous PRDM16. We found no obvious differences in
endogenous PRDM16 expression between differentiated untransduced MPCs and PPARG2–
CEBPB- or PPARG2–CEBPB–PRDM16-programmed adipocytes (Supplementary Fig.
S8F). Endogenous PRDM16 was almost undetectable in pluripotent control cells.
Untransduced MPCs, PPARG2–CEBPB- or PPARG2–CEBPB–PRDM16-programmed
Ahfeldt et al. Page 6
Nat Cell Biol. Author manuscript; available in PMC 2012 June 28.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
adipocytes were analysed at day 5 and day 25 of differentiation. In all conditions,
endogenous PRDM16 was expressed at day 5 of differentiation and showed an increase in
the level of expression at day 25. Endogenous PRDM16 expression was comparable
between untransduced and programmed cells. Next we used a primer that detects viral and
endogenous PRDM16 expression. At day 5 of differentiation in medium containing
doxycyline, we noted a 40-fold increase in the level of PRDM16 expression in the
PPARG2–CEBPB–PRDM16-programmed adipocytes. Doxycycline was removed from the
medium and the PRDM16 expression dropped to comparable low levels in all conditions.
Thus, endogenous PRDM16 expression is not necessary for the differentiation of hPSC-
derived MPCs into brown adipocytes. It is possible that the PRDM16 expression that we
noted in untransduced differentiated MPCs is sufficient to govern brown adipocyte
differentiation or that the differentiation does not rely on PRDM16 in our human in vitro
system.
Programmed white adipocytes exhibit mature functional properties
To investigate the functional capabilities of hPSC-derived white adipocytes, we measured a
key property of mature white adipocytes, the ability to carry out lipolysis, through the
release of glycerol after exposure to the β-adrenergic agonist isoproterenol in
undifferentiated ADSVCs and programmed or unprogrammed, differentiated ADSVCs and
MPCs (n = 3; Fig. 5a). We found that only the programmed, differentiated cells responded
to isoproterenol treatment with the breakdown of triglycerides and release of glycerol
(ADSVCs, P = 0.01; MPCs, P = 0.002). We also assessed the secretion of the hormone
adiponectin, which regulates glucose and fatty acid catabolism and is produced by
adipocytes42,43, using an enzyme-linked immunosorbent assay (ELISA). High levels of
secreted adiponectin were observed from all PPARG2-programmed cell lines, including
several differentiated hPSC-derived MPC lines, with low levels from control cell lines (n =
3; Fig. 5c). Using a similar ELISA assay, we observed low levels of leptin secretion (25 pg
ml−1) into the medium from PPARG2-programmed cells (Supplementary Fig. S8C).
We characterized de novo fatty acid synthesis and storage in hPSC-derived adipocytes using
a tandem mass spectroscopy lipidomics platform44. We profiled the cellular lipid content of
ADSVC- and hPSC-derived white adipocytes programmed with PPARG2 expression and
compared the findings with lipid profiles obtained from primary human white fat (Fig. 5c).
Spearman correlation coefficients (SCC) were analysed across all triglyceride species, and
PPARG2-programmed, differentiated cells were much more similar to primary white
adipocytes (SCC 0.75–0.87) than either unprogrammed, differentiated cells (SCC 0.41–
0.62) or undifferentiated cells (SCC 0.21–0.32; Supplementary Fig. S7). Consistent with
increased expression levels of genes involved in de novo fatty acid synthesis, we observed
higher levels of some short-chain fatty acids in programmed white adipocytes than in
primary white adipose (Supplementary Fig. S7A–C). The diacylglycerol content of
programmed white adipocytes was also slightly altered as compared with primary white
adipose tissue (Supplementary Fig. S7D), which could be the result of either de novo
synthesis or enhanced lipolysis. Membrane lipids, such as phosphatidylcholines, were
similar in all cell types analysed (Supplementary Fig. S7E). Overall, we observed
remarkable congruence among the lipid profiles of programmed white adipocytes and
primary white adipose tissue, especially with respect to triglycerides, which represent the
most abundant lipids in mature white adipocytes.
Finally, we assessed whether the programmed white adipocytes respond to insulin in a
manner similar to mature primary white adipocytes. We analysed insulin signalling of
programmed white adipocytes in the absence and presence of free fatty acids (FFA), an
established contributor to induce insulin resistance in white adipocytes45. We examined
insulin response by assessing protein expression levels of AKT and phosphorylated AKT
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(pAKT(Ser 473); Fig. 5d). In the basal starved state, no pAKT(Ser 473) product was
detected; administration of insulin robustly upregulated pAKT(Ser 473). Co-administration
of FFA decreased the level of insulin-induced phosphorylation of AKT, demonstrating that
the hPSC-derived adipocytes appropriately model FFA-induced insulin resistance. We also
analysed the uptake of [3H]2-deoxy-d-glucose (Fig. 5e) and found that the basal level of
glucose uptake was similar between PPARG2-programmed and unprogrammed cells. After
exposure to insulin, a significant increase in the level of glucose uptake was noted in both
cell types (P = 0.05 for unprogrammed cells, P = 0.0007 for programmed cells) but was
substantially higher in the PPARG2-programmed cells (P = 0.009). Taken together, these
results validate programmed white adipocytes as a model of insulin response and insulin
resistance.
Programmed brown adipocytes exhibit mature functional properties
The characteristic function of brown adipocytes is thermogenesis, driven by the catabolic
breakdown of lipids. We therefore measured the release of glycerol from our various cells to
determine the extent of lipolysis on exposure to forskolin. As expected, both white and
brown hPSC-derived adipocytes exhibited a significantly higher level of glycerol release in
response to forskolin treatment (Fig. 6a) when compared with unprogrammed cells. For the
programmed brown adipocytes, we further examined the response to the β-adrenergic
agonist isoproterenol and observed a significant increase in the level of glycerol release
when compared with unprogrammed cells (Supplementary Fig. S8D).
To further distinguish between white and brown adipocytes at a functional level, we
extended our characterization to the mitochondrial function of our cells. We analysed the
oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) using an
extracellular flux analyser (Fig. 6b,c); the basal OCR and ECAR rates were highest in the
programmed brown adipocytes. We then injected compounds that modulate mitochondrial
function sequentially and measured the effect on OCR and ECAR after the addition of each
compound. We first administered oligomycin to determine ATP turnover and the degree of
proton leak. At the baseline, the programmed brown adipocytes showed slightly elevated
levels of proton leak when compared with unprogrammed cells. After the addition of the
electron transport chain decoupler carbonyl cyanide-m-chlorophenylhydrazone (CCCP), we
measured the maximal respiratory capacity. Programmed brown adipocytes showed
significantly higher levels of OCR and ECAR when compared with the unprogrammed cells,
whereas programmed white adipocytes did not. Finally, we administered antimycin to
inhibit the flux of electrons through complex III and prevent oxygen consumption by the
cytochrome c oxidase in the mitochondria. The OCR for all cell types dropped to post-
oligomycin levels. Taken together, these results confirm that programmed brown adipocytes
have a significantly increased level of mitochondrial activity, an important functional
characteristic of brown adipose tissue.
In vivo transplantation of hPSC-derived adipocytes
We subcutaneously administered hPSC-derived brown and white adipocytes, as well as
control 3T3-F442A cells, to immunocompromised Rag2−/−Il2rg−/− mice to study the
function of the cells in vivo. The transplants were collected and histologically examined
after 4–6 weeks; importantly, no teratomas were observed (n = 20). We confirmed the
extracorporeal origin of the collected cells by immunohistochemical staining with
MAB1281, a human-specific nuclear antibody that does not stain nuclei in mouse cells (Fig.
7a,b and Supplementary Fig. S8E). Programmed white adipocytes stained positively for the
adipocyte marker CEBPA, whereas programmed brown adipocytes were positive for UCP1
(Fig. 7a,b) in adjacent slides. Transplanted programmed white and brown adipocytes had a
morphology characteristic of primary adipocytes. Finally, we assessed the white and brown
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adipocyte transplants by fluordeoxyglucose (18FDG) uptake followed by positron-emission
tomography–computed tomography (PET–CT), a technique that has been used to detect
brown adipose tissue in adult humans11,13,46,47. Consistent with brown adipocytes acting as
a ‘glucose sink’, the transplanted hPSC-derived brown adipocytes were highly FDG-avid
and exhibited a clear PET signal when compared with hPSC-derived white adipocytes (Fig.
7c).
DISCUSSION
We have established efficient protocols to generate white and brown adipocytes from
hPSCs. Brown adipocytes show distinct morphology and gene expression profiles from
white adipocytes, and each type of cell demonstrated functional properties that are
characteristic of the corresponding tissue types in vivo. Transplantation of the cells into
mice yielded tissues with functional and morphological similarities to primary white and
brown adipose tissues. Taken together, these experiments confirm the identity and maturity
of the hPSC-derived white and brown adipocytes and indicate that the cells could be used to
faithfully model human disease.
METHODS
Methods and any associated references are available in the online version of the paper at
http://www.nature.com/naturecellbiology
METHODS
Maintenance of pluripotent cells, generation of MPCs and adipocyte differentiation
hESCs and hiPSCs were cultured feeder free on Geltrex (Invit rogen) in the chemically
defined medium mTESR1 (Stem Cell Technologies). To induce differentiation of hESCs
and hiPSCs into embryoid bodies, hPSCs were disaggregated with dispase into small clumps
containing 5–10 cells and transferred to low-adhesion plastic 6-well dishes (Costar Ultra
Low Attachment; Corning Life Sciences) in growth medium containing DMEM, 15% FBS
and 1% GlutaMAX After 7 days in suspension culture, embryoid bodies were collected and
replated on gelatin-coated 6-well dishes in medium containing DMEM, 10% FBS and 1%
GlutaMAX. After cells reached confluency (in approximately 5 days), they were trypsinized
(0.25% trypsin) and replated on cell culture dishes containing MPC growth medium
containing DMEM, 15% FBS, 1% GlutaMAX and 2.5 ng ml−1 bFGF (Aldevron). Cells
were passaged with a 1:3 split ratio and used for differentiation experiments before passage
8. Adipogenic differentiation was carried out for 21 days using adipogenic differentiation
medium containing DMEM, 7.5% knockout serum replacement (KOSR; Invitrogen), 7.5%
human plasmanate, 0.5% non-essential amino acids, 1% penicillin and streptomycin, 0.1 μM
dexamethasone, 10 μg ml−1 insulin (Sigma) and 0.5 μM rosiglitazone. Adipogenic
differentiation medium was supplemented for 16 days with doxycyline (700 ng ml−1), and
afterwards cells were maintained in culture in the absence of doxycycline until day 21 or
longer as experiments required.
Derivation and maintenance of ADSVCs
Primary human adipose tissue was obtained from surgical waste of patients who had
undergone elective surgery Adipose was digested with Liberase (Roche) for 1 h with gentle
shaking at 37 °C Digested tissue was forced through a 250 μm filter, and the filtrate was
collected and centrifuged. The resulting stromal vascular cell pellet was washed twice with
PBS and plated onto gelatin-coated plates (0.1%) in ADSVC growth media (DMEM, 10%
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FBS, 1% penicillin and streptomycin and 2.5 ng ml−1 bFGF (Aldevron)). ADSVCs were
passaged using trypsin on reaching confluency.
Inducible transgenes
To generate pLV-tetO-attR1/R2, pLV-tetO (ref. 48) was linearized with EcoRI followed by
treatment with DNA polymerase I, large (Klenow) fragment to fill in and blunt the 5′
overhangs. The resulting fragment was ligated with the Reading Frame A Gateway cassette
(Invitrogen). To generate pENTR-PPARG2, the human PPARG2 cDNA was amplified from
a publicly available plasmid (Addgene #11439) and recombination sites compatible with the
Gateway system (Invitrogen) were added. To generate lenti-PPARG2 plasmid, pENTR-
PPARG2 and pLV-tetO-attR1/R2 were recombined with LR Clonase II as described by the
manufacturer’s instructions (Invitrogen). All clones were confirmed by restriction digest
screening and sequencing. Following a similar procedure, pENTR-eGFP, pENTR-PRDM16,
pENTR-CEBPB, lenti-eGFP, lenti-PRDM16 and lenti-CEBPB were generated. The eGFP
transcript was amplified from a commercially available plasmid (Addgene #14430) as well
as the PRDM16 (Origene NM_022114) and the CEBPB transcript (Origene NM_005194).
Production of lentivirus and transduction
A third-generation, Tat-free pack aging system49 was used to produce recombinant
lentivirus. The vectors—either lenti-rtTA plasmid50–53 or lenti-PPARG2 plasmid—together
with the two packaging plasmids—pMDL, pREV—and the plasmid coding for VSV-G
envelope were transfected into HEK293T cells using calcium chlorate as previously
described54 Cell media/viral supernatant was collected 48 and 72 h after transfection, passed
through a 0.45 μm filter and used directly for the transduction of cells. We determined the
RNA copy numbers per millilitre of viral supernatant using the lenti-X RT–qPCR titration
kit. The range varied between 7.5× 107 copies ml−1 and 1.5 × 108 copies ml−1 and was
influenced both by the packaged transgene and the specific preparation conditions.
Cells were transduced with lentiviral supernatant 24 h after passaging at about 40%
confluency. Twelve-well dishes were transduced with 500 μl lenti-rtTA virus and 500 μl
lenti-PPARG2 virus per well. Six-well dishes were transduced using 1000 μl lenti-rtTA
virus and 1000 μl lenti-PPARG2 virus per well. Cells were incubated at 37 °C for 4 h, viral
supernatant was removed and cells were washed with PBS. Cells were further cultured in
growth medium until differentiation was initiated through the administration of 700 ng ml−1
doxycycline and switch to adipogenic medium.
Flow cytometry analysis
Cells were trypsinized, washed with PBS and centrifuged at 200g for 5 min. Cells were
counted and 1 × 106 cells were transferred into polypropylene tubes. Staining for surface
antigens was carried out using antibody conjugated to PE, FITC, PE–Cy7 or PE–Cy5 (PE–
CD73 and ecto-5′ nucleotidase AD2, BD Pharmingen; PE–CD105 (Endoglin) eBioscience;
PE–Stro1, Santa Cruz; FITC–CD44, eBioscience; PE–Cy5–CD29, eBioscience; PE–Cy7–
CD4, BD Pharmingen; PE–CD19, eBioscience). Typically 1 × 106 cells in 80 or 95 μl PBS
with 5% FBS were stained using 20 μl or 5 μl antibody solution (final volume 100 μl). Ten-
thousand events per cell type were acquired on a FACSCalibur flow cytometer (BD
Biosciences). Data were analysed using the FlowJo software package (Treestar).
Immunocytochemistry
Immunostaining was carried out using the following antibodies and dilutions: α-FABP4
1:200 (R&D Systems), α-perilipin 1:200 (Sigma), α-CEBPA 1:100 (Santa Cruz), α-
PPARG2 1:200 (Santa Cruz), α-MAB1281 1:50 (Millipore), α-PRDM16 1:100 (Sigma), α-
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CEBPB 1:100 (Sigma), α-UCP1 1:200 (Sigma), MitoTracker (Invitrogen) and Alexa Fluor
secondary antibodies (Invitrogen). Lipid droplets were stained using BODIPY neutral lipid
dye. Hoechst or DAPI stain was used to mark cell nuclei. Images were acquired with either a
Nikon Digital Sight camera mounted to a Nikon Eclipse Ti-S microscope, an Olympus
DP72 camera mounted to a Olympus 1X71 microscope or a Zeiss LSM510 Meta confocal
microscope. The NIS-Elements and Olympus DP2-BSW software packages were used for
image analysis.
RNA extraction, cDNA synthesis and RT–qPCR
Total RNA from human cell lines and human fat was extracted with Trizol (Invitrogen) and
purified using the RNeasy mini kit (Qiagen) according to the manufacturer’s instructions.
The RNA yield was determined using the NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies). Total RNA (1 μg) was converted to cDNA using the Superscript
First-Strand kit (Invitrogen). RT–qPCR was carried out using a Realplex Mastercycler
(Eppendorf) with the Quantifast-SYBR Green PCR mix (Qiagen) with 1 μl cDNA per
reaction. Primer sequences are listed in Supplementary Fig. S1D.
Transcriptional profiling
Total RNA from human cell lines or human fat was extracted with Trizol (Invitrogen) and
purified using the RNeasy mini kit (Qiagen) according to the manufacturers’ instructions.
RNA quality was assessed using an Agilent bioanalyser. RNA probes for microarray
hybridization were prepared and hybridized to the Affymetrix GeneChip Human Gene 1.0
ST microarray, Human Genome U133 Plus 2.0 array and Agilent GE G3 arrays.
Microarrays were quantile normalized and median centred using the RMA feature in the
Bioconductor affy package in R. Probe sets were mapped to and median collapsed on to
HUGO gene symbol identifiers. Agilent features were extracted using the Feature Extraction
software. Normalization for the Agilent arrays was carried out by converting log2 intensity
values to ratios of the 75th percentile intensity for each array and median centred. Agilent
arrays were also batch corrected using the ComBat software package in R (ref. 55). SAM
was used to rank order genes present on both arrays to calculate the Spearman rank
correlation, which is the Pearson correlation of rank-ordered lists. The hypergeometric test
to measure overlap between differentially expressed lists from both platforms was carried
out in R. Unsupervised hierarchical clustering was carried out using Pearson’s correlation as
a similarity metric across all probes with Cluster 3.0. Heat maps were generated with Java
TreeView. Differential expression was determined using the Samr package in R using a
cutoff of 5% local FDR. GO term analysis was carried out on differentially expressed genes
using DAVID Bioinformatics Resources 6.7 (ref. 56) with the HuGene 1.0 ST microarray
background.
All generated data sets have been submitted to publicly available databases under GEO
accession numbers: GSE30041 SuperSeries, GSE30038 Affymetrix, GSE30039 Agilent.
Lipolysis assay
To measure lipolysis activity, day 21 adipocytes, differentiated from both hPSCs and
ADSVCs, were starved in DMEM containing 1% FBS for 1 h. Cells were then incubated in
HBSS (Hank’s balanced salt solution) with 2% fatty-acid-free BSA alone, with 1–10 μM
isoproterenol or with 10 μM forskolin. The culture medium was collected for glycerol
measurement using the free glycerol reagent (Sigma #F6428). Protein concentrations used to
normalize glycerol content were measured using the Bradford protein assay (BioRad).
Glycerol release was expressed in micrograms of glycerol per milligram of total protein or
the lowest value is set to 1.
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Adiponectin and leptin ELISA
Cell culture supernatants were analysed for adiponectin using the Protein Immunoassay kit
(Millipore Corporation) as per the manufacturer’s protocol. Briefly, the samples and kit
controls were loaded onto a Millipore Multiscreen BV 96-well filter plate. Serial dilutions of
standards were prepared in parallel and added to the plate. Millipore Multiplex beads were
vortexed and sonicated for 30 s and 25 μl was added to each well. Samples were incubated
on a plate shaker at 600 r.p.m. in the dark at 4 °C overnight. The plate was applied to a
Millipore multiscreen vacuum manifold and washed twice with 200 μl of wash buffer. A 50
μl volume containing biotinylated human adiponectin and leptin detection antibodies was
added to each well. The plate was incubated on a plate shaker at 600 r.p.m. in the dark at
room temperature for 1 h. Streptavidin–phycoerythrin (50 μl) was added directly to each
well. The plate was incubated on a plate shaker at 600 r.p.m. in the dark at room temperature
for 30 min. The plate was applied to the vacuum manifold and washed twice with 200 μl of
wash buffer, and each well was resuspended in 100 μl sheath fluid and shaken for 5 min.
The assay plate was transferred to a Luminex 200 instrument for analysis. Cytokine
concentrations were calculated using Upstate Beadview software with a five-parameter
curve-fitting algorithm applied for standard-curve calculations.
Metabolomic profiling
All experiments were carried out using three biological replicates of cells grown on 10 cm
plates. Medium was replaced 2 h before the extraction of the lipids. Ice-cold isopropanol (3
ml; HPLC grade) was added, and cells were scraped and transferred into 15 ml centrifuge
tubes. The extracts were incubated for 1 h at 4 °C and then vortexed and centrifuged at
2,300g. for 10 min. The supernatant was transferred to a new 15 ml centrifuge tube and
stored at −20 °C.
All data were acquired using an Applied Biosystems QSTAR XL hybrid quadrupole/time-
of-flight mass spectrometer57. MultiQuant software (version 1.1; Applied Biosystems/Sciex)
was used for automated peak integration, and peaks were manually reviewed for quality of
integration. Internal standard peak areas were monitored for quality control and used to
normalize analyte peak areas.
Western blot analysis
BJ-RiPS-MPC-derived adipocytes were starved overnight in DMEM containing 2% fatty
acid free BSA. To induce insulin resistance, FFA mixture (lauric, myristic, linolein, oleic
and arachidonic acids from Sigma) was used at 0.5 mM–1 mM for 1 h. Insulin stimulation
was carried out at 100 nM for 20 min. Cells were lysed in cold RIPA buffer (60 mM Tris–
HCl at pH 7.4, 150 mM NaCl, 0.25% SDS and 1% NP40) containing 10 mM NaF, 1 mM
Na3VO4 and complete protease inhibitor (Roche). Western blot analysis was carried out
using the following antibodies: total AKT (Cell Signaling #9272), phospho-Ser-473 AKT
(Cell Signaling #9271) and lamin A/C (Fisher/Millipore #3211).
Glucose uptake assay
Adipocytes were serum-starved in 0.2% BSA DMEM overnight. Then, cells were incubated
in KRH buffer (121 mM NaCl, 4.9 mM KCl, 1.2 mM MgSO4, 0.33 mM CaCl2 and 12 mM
HEPES, at pH 7.4) in the absence or presence of 100 nM insulin for 30 min at 37 °C,
followed by washing three times in KRH buffer. Glucose uptake was measured by
incubating cells with 0.5 μCi ml−1 2-deoxy-d-[3H]glucose (Perkin-Elmer) for 5 min at 37
°C. After three washes with cold PBS, cells were lysed with 1% Triton X-100 solution and
subjected to scintillation counting. Nonspecific uptake was measured in the presence of 10
μM cytochalasin B and was subtracted from the total uptake.
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Transplantation
PPARG2- or PPARG2–CEBPB-transduced HUES 9 MPCs were differentiated for 14 days.
To avoid rejection, differentiated cells were injected subcutaneously into Rag2−/−; Il2γc
mice. Four–six weeks after transplantation, mice were killed to collect fat pads. 3T3-F442A
cells were injected into the same mice as a positive control. Tissues at the transplantation
site were embedded in paraffin and stained after sectioning.
PET analysis
To detect the molecular activity of programmed human white and brown adipose tissue,
mice were intravenously injected with [18F]FDG, a glucose analogue, 2 h before PET
acquisition. The skin with transplanted human adipose tissue was removed and scanned to
visualize the PET signal in the ex vivo sample. PET imaging was carried out over 2 h using
an Inveon small-animal scanner (Siemens). Osirix was used for visualization of the DICOM
images and obtained images were reconstructed using IRM software.
Measurement of cellular OCR and ECAR
Cells were plated in gelatin-coated XF 24-well cell culture microplates (Seahorse
Bioscience) and differentiated into adipocytes. Cells were incubated in pre-warmed
unbuffered DMEM medium (DMEM containing 2 mM GlutaMAX, 1 mM sodium pyruvate,
1.85 g l−1 NaCl and 25 mM glucose) for 1 h. The oxygen consumption was measured by the
XF24 extracellular flux analyser (Seahorse Biosciences). Mitochondrial biogenesis was
profiled by injecting perturbation drugs, 2 μM oligomycin, 0.5 μMFCCP (carbonyl cyanide-
p-trifluoromethoxyphenylhydrazone) and 5 μM antimycin A, in succession. OCR and
ECAR were determined by plotting the oxygen tension and acidification of the medium in
the chamber as a function of time and normalized by protein concentration (picomoles per
minute per milligram), respectively.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Experimental scheme and characterization of hPSC-derived MPCs. (a) Experimental
scheme for the differentiation of ADSVCs and hPSCs into white and brown adipocytes.
hPSCs were differentiated as embryoid bodies and then re-plated and passaged to generate
MPCs. MPCs and ADSVCs were either not infected (unprogrammed) or transduced
(programmed) with lentivirus constitutively expressing the lenti-rtTA M2 domain and virus
carrying the inducible cDNA transgenes PPARG2 (lenti-PPARG2), CEBPB (lenti-CEBPB)
and PRDM16 (lenti-PRDM16). All differentiated cells were cultured in media containing
adipogenic factors and doxycycline for 14–16 days and maintained without doxycycline
until 21 days before analysis. Four hPSC lines were used—two hESC lines, HUES 8 and 9,
and two induced pluripotent stem cell (iPSC) clones generated by reprogramming BJ
fibroblasts with modified ribonucleic acids, BJ RiPSC. (b) Top, table showing the results of
the flow cytometry analysis of the hPSC lines BJ RiPS #1.1 and HUES 9 as well as MPCs
derived from these lines. Cells were stained for the surface antigens Stro1, CD105, CD73,
CD44, CD29 and CD4. The numbers represent the percentage of positive cells. Where
appropriate, positive stainings were distinguished as high- or low-expression groups.
Bottom, flow cytometry results for the surface antigens Stro1, CD105, CD73, CD44 and
CD29 presented as histograms: BJ RiPS #1.1 p15 (blue), BJ RiPS #1.1 MPC p6 (green),
HUES 9 p30 (orange) and HUES 9 MPC p7 (violet). The x axis indicates the relative
fluorescence intensity from 10 to 100.000 on a logarithmic scale. The y axis represents the
percentage of cells. (c) Doxycycline-inducible expression of PPARG2 and eGFP. Top, BJ
RiPS MPCs transduced with lenti-rtTA and doxycycline-inducible eGFP virus and cultured
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either in the presence (+DOX; top panels) or absence (−DOX; bottom); Bottom, RT–qPCR
assays for viral PPARG2 cDNA expression normalized to HPRT: BJ RiPS MPCs
transduced with lenti-rtTA only (control); BJ RiPS MPCs transduced with lenti-rtTA and
lenti-PP ARG2 cultured in the absence (−DOX) or presence (+DOX) of doxycycline.
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Figure 2.
Programming hPSC-derived MPCs with PPARG2, PPARG2–CEBPB or PPARG2–
CEBPB–PRDM16 generates white and brown adipocytes. (a) Efficiency of white adipocyte
differentiation. Top, table showing the efficiency of white adipocyte formation from cells in
adipogenic media alone (untransduced) or PPARG2-programmed differentiated cells
(PPARG2) as determined by the ratio of Hoechst-positive and CEBPA-positive nuclei.
Bottom, representative images of Hoechst-stained (top left panel) and CEBPA-stained
(bottom left panel) nuclei from HUES 9 MPCs programmed with PPARG2 (×100
magnification). The right panels illustrate the threshold assignment of positive nuclei and
counting carried out by the ImageJ analysis software. (b) Programming hPSCs into white
adipocytes. HUES-8-derived MPCs were differentiated with adipogenic media alone (top
panels; untransduced) or in combination with exogenous PPARG2 expression (bottom
panels; PPARG2). From left to right: bright-field images illustrating the morphology of
immature (top panel) and mature (lower panel) white adipocytes; fluorescence micrographs
of corresponding immunostains with antibodies against the adipocyte marker protein FABP4
(red) and the neutral lipid dye BODIPY (green); all cells were co-stained with Hoechst
(blue) to identify nuclei (×100 magnification). (c) hPSC-derived white adipocytes express
endogenous CEBPA and PPARG2. BJ-RiPSC-derived MPCs were differentiated and
programmed with exogenous PPARG2 expression for 16 days and, 5 days after withdrawal
of doxycycline, stained with antibodies against CEBPA (red; lower left panel) or PPARG2
(red; lower right panel). All cells were also stained with the neutral lipid dye BODIPY
(green, both lower panels, ×100 magnification). The upper panels show corresponding
bright-field images. (d) hPSC-derived brown adipocytes express UCP1 and can be
efficiently labelled with MitoTracker. BJ-RiPSC-derived MPCs were differentiated with
adipogenic media alone (top panels; untransduced) or programmed with either exogenous
PPARG2 + CEBPB (middle panel) or exogenous PPARG2 + CEBPB + PRDM16 (lower
panel) expression for 14 days and, 7 days after withdrawal of doxycycline, labelled with
MitoTracker (red) or stained with antibodies against UCP1 (green). The left panels show
corresponding bright-field images (all images ×200 magnification).
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Figure 3.
Programmed adipocytes exhibit a mature white or brown adipocyte gene expression profile.
(a) hPSC-derived white adipocytes express mature marker genes. RT–qPCR assays were
carried out for adipocyte marker genes PPARG2, CEBPA, FABP4, ADIPOQ, HSL and
LPL. The expression values represent three biological replicates and are shown relative to
HPRT expression in each sample. White bars represent cells that were not exposed to
adipogenic media (undifferentiated); grey bars represent cells that were exposed to
adipogenic media but not transduced with lenti-PPARG2 (−PPARG2); black bars represent
cells that were exposed to adipogenic media and transduced with lenti-PPARG2
(+PPARG2). P values represent two-tailed Student’s t-tests between − PPARG2 and
+PPARG2 expression values for each cell line. n = 3, *P < 0.05, **P < 0.01 (s.d.). P values
shown under each gene name represent results of analysis of variance among all expression
values for −PPARG2 and +PPARG2 cell lines. (b) Comparison of hPSC-derived white
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adipocytes and brown adipocytes. RT–qPCR assays were carried out for a range of white or
brown adipocyte marker genes, PPARG2, PGC1a, FABP4, ADIPOQ, HSL, LPL, CYC1,
ELOVL3 and UCP1. Expression values represent three biological replicates and are shown
relative to HPRT expression and relative to the lenti-PPARG2 condition set as 1. White bars
represent cells that were differentiated with adipogenic media alone (untransduced); black
bars represent cells that were exposed to adipogenic media and transduced with lenti-
PPARG2 (+PPARG2); grey bars represent cells that were exposed to adipogenic media and
transduced with lenti-PPARG2 and lenti-CEBPB (+PPARG2–CEBPB, light grey bars) or
with lenti-PPARG2, lenti-CEBPB and lenti-PRDM16 (+PPARG2–CEBPB–PRDM16, dark
grey bars) respectively. All experiments were carried out with BJ-RiPSC-derived MPCs. P
values represent two-tailed Student’s t-tests between the PPARG2 and PPARG2–CEBPB or
PPARG2–CEBPB–PRDM16 set-ups respectively. Values for each cell line, n = 3, *P <
0.05, **P < 0.01 (s.d.).
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Figure 4.
Global transcriptional analysis confirms the identity of programmed hPSC-derived white
and brown adipocytes. (a) ADSVCs, HUES 9 MPCs and BJ RiPS MPCs either not exposed
to adipogenic media (undifferentiated) or cultured with adipogenic media and transduced
with lenti-PPARG2 (+PPARG2) were compared with primary adipocytes using Affymetix
1.0 ST microarrays. Shown is a row-centred heat map of hierarchical clustering carried out
on the 2,136 differentially expressed genes at a 5% FDR. Probe sets are coloured according
to the average expression level across all samples, with blue denoting a lower expression
level and red denoting a higher expression level. (b) Row-centred heat map and hierarchical
cluster of an adipo-specific gene panel across the same samples as in a. Probe sets are
coloured according to the average expression level across all samples, with blue denoting a
lower expression level and red denoting a higher expression level. (c) Row-centred heat map
hierarchical cluster of a brown and white adipo-specific gene panel across the same samples
as in a and b (white adipocytes, primary white adipose tissue and undifferentiated MPCs) in
addition to PPARG2–CEBPB–PRDM16-programmed MPCs (brown adipocytes) on the
Agilent G3 human GE array platform. Probe sets are coloured according to the average
expression level across all samples, with blue denoting a lower expression level and red
denoting a higher expression level.
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Figure 5.
Programmed hPSC-derived white adipocytes exhibit mature functional properties. (a) hPSC-
derived adipocytes carry out lipolysis. Glycerol was measured in the supernatant of
ADSVCs and HUES-9-derived MPCs that were either not exposed to adipogenic media
(undifferentiated) or exposed to adipogenic media without (−PPARG2) or with exogenous
PPARG2 expression (+PPARG2) followed by either treatment with (+iso) or without (−iso)
isoproterenol. The quantity of glycerol released (in micrograms) was normalized to the total
amount of protein (in milligrams) for each sample. n = 3, **P < 0.01 (s.e.m.). (b) hPSC-
derived adipocytes secrete adiponectin. ELISA for adiponectin in the supernatant of cells
exposed to adipogenic media and either not transduced with lenti-PPARG2 (−PPARG2) or
transduced with lenti-PPARG2 (+PPARG2). Experiments carried out as biological
triplicates, with the exception of BJ RiPS MPCs. n = 3, *P < 0.05, **P < 0.01 (s.d.). (c)
Lipid profiling of ADSVC- and hPSC-derived adipocytes. The cellular lipid content of
PPARG2-programmed ADSVCs, HUES 9-derived MPCs and BJ-RiPS-derived MPCs was
analysed using a tandem mass spectroscopy lipidomics platform and compared with the lipid
content of primary adipose tissue. Shown are the relative abundances of several long-chain
triacylglyceride species in each cell type. The x axis denotes the total number of carbon
atoms in the fatty-acid chains:unsaturated bonds. The y axis represents the relative
abundance of each lipid analyte. (d) Attenuation of insulin-induced Ser-473 phosphorylation
on AKT by FFAs. BJ-RiPS-MPC-derived adipocytes were treated using either insulin alone,
BSA-bound FFAs or with both. Phosphorylation of AKT was determined in the whole-cell
lysate by immunoblotting with the phospho-specific AKT (Ser 473) antibody. (e) Glucose
uptake in BJ-RiPS-MPC-derived adipocytes was assessed by the transport of [3H]-2-deoxy-
D-glucose following insulin stimulation. MPCs were exposed to adipogenic media without
(−PPARG2) or with exogenous PPARG2 expression (+PPARG2) followed by either
treatment with (+insulin) or without (−insulin) insulin. The quantity of [3H]2-deoxy-D-
glucose transported into the cells was normalized to CytoB and the results are shown as
c.p.m. n = 3, *P < 0.05, **P < 0.01 (s.e.m.). Uncropped images of blots are shown in
Supplementary Fig. S9.
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Figure 6.
Programmed hPSC-derived brown adipocytes demonstrate mature functional properties. (a)
Glycerol release assay with hPSC-derived brown and white adipocytes. Glycerol was
measured in the supernatant of HUES-9-derived MPCs that were differentiated with
adipogenic media alone (untransduced, white bars), with exogenous PPARG2 expression
(+PPARG2, black), with expression of a combination of lenti-PPARG2 and lenti-CEBPB
(+PPARG2–CEBPB, light grey bars) or with a combination of lenti-PPARG2, lenti-CEBPB
and lenti-PRDM16 (+PPARG2–CEBPB–PRDM16, dark grey bars). After differentiation of
the cells, measurements were made at the basal level and after exposure to forskolin (+FSK).
The quantity of released glycerol (in micrograms) was normalized to the total amount of
protein (in milligrams) for each sample. n = 3, Student’s t-test **P < 0.01 (s.e.m.). (b,c)
Comparison of the OCR and ECAR of hPSC-derived brown and white adipocytes. The OCR
and ECAR were determined using no cells (brown line) and cells differentiated with
adipogenic media alone (untransduced) as controls. Cells in which PPARG2 was
exogenously expressed (+PPARG2) are represented with a green graph, cells that were
transduced with lenti-PPARG2 and lenti-CEBPB (+PPARG2-CEBPB) are shown with a
black line and lenti-PPARG2, lenti-CEBPB and lenti-PRDM16 (+PPARG2–CEBPB–
PRDM16)-transduced cells are indicated by a blue line. The OCR and ECAR were
measured over time in approximately 5 min intervals. The first two measurements were
conducted to establish a baseline rate, followed by three measurements after the addition of
oligomycin, an ATPase inhibitor (I). By uncoupling the proton gradient with CCCP, the
maximum OCR and ECAR rates were determined over the next three time intervals (II).
Finally, at two time points, measurements were conducted after inhibition of the
mitochondrial respiratory chain with antimycin (III). All experiments were conducted with
BJ-RiPSC-derived MPCs. P values represent two-tailed Student’s t-tests between
untransduced and transduced cells. Values for each cell line, n = 4, *P < 0.01, **P < 0.001
(s.e.m.).
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Figure 7.
Generation of functional hPSC-derived brown and white adipose tissue in vivo. (a)
HUES-9-derived MPCs were transduced with lenti-PPARG2 and after 2 weeks of
differentiation collected and injected subcutaneously into RAG2; IL2γC double-knockout
mice. Four to six weeks after the injection, prominent cell growth was visible at the injection
site. This fat pad was collected, sectioned and stained. Top panels, bright-field morphology
of the transplant sections (left); zoomed bright-field image of the transplant section
(middle); immunohistochemistry overlay of stainings for nuclear marker DAPI (blue),
staining with a human-specific nuclei marker MAB1281 (green) and staining with antibody
against CEBPA (red; right). Bottom panels, staining with nuclear marker DAPI (left),
staining with a human-specific nuclei marker MAB1281 (middle) and staining with antibody
against CEBPA (right). (b) HUES-9-derived MPCs were transduced with a combination of
lenti-PPARG2, lenti-CEBPB and lenti-PRDM16 and transplanted and collected as described
above. Specimens were sectioned and adjacent slides were stained with UCP1 and
MAB1261, a human-specific nuclei marker (all images ×200 magnification). (c) Left, FDG
intensity. Middle, PET image of mouse skin with transplants from HUES 9 MPC
(PPARG2), HUES 9 MPC (PPARG2–CEBPB–PRDM16) and control 3T3-F442A cells.
Right, the corresponding bright-field image of mouse skin with transplants from HUES 9
MPC (PPARG2), HUES 9 MPC (PPARG2–CEBPB–PRDM16) and control 3T3-F442A
cells.
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